Mercado mundial de sistemas robóticos médicos: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de sistemas robóticos médicos

La terapia de rehabilitación robótica proporciona un entrenamiento intenso y de dosis alta, lo que la hace beneficiosa para los pacientes con trastornos motores provocados por enfermedades de la médula espinal o accidentes cerebrovasculares. El efector terminal y el exoesqueleto son los componentes principales de los dispositivos robóticos utilizados para la rehabilitación motora. La población de edad avanzada es más susceptible a las heridas y otras afecciones que requieren tratamiento quirúrgico debido a los cambios patológicos y psicológicos que trae consigo el envejecimiento. La creciente demanda de cirugías laparoscópicas precisas y el aumento de las lesiones por traumatismos son los principales factores que impulsan la expansión del mercado. Además, se prevé que el mercado en las economías emergentes se vea impulsado por el aumento del gasto sanitario per cápita y el desarrollo de la tecnología de equipos médicos.

Data Bridge Market Research analiza que el mercado de sistemas robóticos médicos, valorado en USD 18,90 mil millones en 2022, alcanzará los USD 68,10 mil millones para 2030, creciendo a una CAGR del 17,38% durante el período de pronóstico de 2023 a 2030. Además de los conocimientos sobre escenarios de mercado como el valor de mercado, la tasa de crecimiento, la segmentación, la cobertura geográfica y los principales actores, los informes de mercado seleccionados por Data Bridge Market Research también incluyen un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance del informe y segmentación del mercado      

Market Definition

Medical robotic systems are advanced medical systems based on artificial intelligence principles and use robotics and automation during a medical procedure, as is evident from the name alone. The need and the surgical site are considered when designing a wide range of medical robotic systems. During a surgical procedure, robotic medical systems offer greater accuracy and precision.

Medical Robotic System Market Dynamics

Drivers

• Rising technological advancements

Rapid technological development in surgical technology and equipment has paved the way for the market's expansion. Additionally, the market will continue to grow due to rising technological developments in areas such as 3D imaging, remote navigation, robotic catheter control systems (CCS), motion sensors, and others. Additionally, more products receiving FDA approval is anticipated to fuel market expansion during the forecast period.

• More accuracy drives the market growth

The increased demand for robotic minimally invasive surgeries is mainly attributable to their benefits, which include fewer cuts, smaller incisions, decreased pain, reduced scarring, higher levels of safety, and quicker recovery times. Furthermore, the procedures give the surgeons extremely sophisticated visualization abilities by using HD cameras to show microscopic structures. Thereby ensuring higher accuracy and greater control.

Opportunities

• An increase in medical tourism can create lucrative opportunities to grow

The developing nations are anticipated to present significant opportunities for market participants. Through expanding target patient populations and increasing medical tourism, emerging regions have seen a steady increase in the percentage of surgical procedures over the past ten years. Since today's government has even started travel plans and medication for travelers is a blessing, the increase in medical support for tourism will result in a rise in demand in medical robotics system.

• Competencies in research and development spur rapid market expansion

Rising R&D spending, particularly in developed and developing nations, will create profitable market expansion opportunities for medical equipment and supplies. Research and development activities are being carried out to integrate cutting-edge technologies in healthcare facilities, and the penetration rate in particular geographies are also boosting the market growth rate. Over the past few years, there has been a significant increase in the study of therapeutic rehabilitation robots and their production.

Restraints/Challenges

• High costs can impede the market growth

Limited infrastructure, high costs of robotically assisted surgeries, and high research and development costs are anticipated to restrain market expansion. Additionally, the market is expected to face challenges from a lack of favorable reimbursement scenarios and technology penetration in developing economies, high capital investment and maintenance costs infrastructure in low- and middle-income nations. Surgery with a robot is more expensive than traditional surgery. For instance, the cost of the CyberKnife radiosurgery robotic system ranges from USD 4.2 to 5.2 million per unit, while the cost of the most widely used robotic system, the da Vinci system, is between USD 1.0 million and USD 3.0 million. Furthermore, maintenance will cost an additional $100,000.

• Lack of skills can restrict the market

Lack of skills causes a decline in the medical robot system because it prevents proper or inappropriate use of technology and slows down system advancement. With ongoing technological advancement, it is essential to have a person who can use it to the best of their ability; otherwise, the market will be hampered.

This medical robotic system market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the medical robotic system market contact Data Bridge Market Research for an analyst brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, An agreement between Titan Medical and Medtronic for a constrained development program was announced. According to the agreement, Titan Medical will use gynecological procedures as the initial application for its surgical robot. Medtronic will assess the effectiveness of Titan's instruments and cameras in those procedures.
• In 2022,  The U.S. Food and Drug Administration approved the integration of a mobile cone-beam CT (CBCT) imaging technology and the Ion Endoluminal System used for robotic-assisted bronchoscopy, according to Intuitive, a leading global technology company in minimally invasive care and the inventor of robotic-assisted surgery.
• In 2021, In North America, Renishaw announced that an agreement had been reached with Verisurf Software Inc. This aids the business in expanding technological advancement and its plan to support additional REVO sensors.
• In 2020,  The top 20 global medical device company, which employs about 50,000 people, has placed an order with Robotic Assistance Devices (RAD), the company's wholly-owned subsidiary, for what RAD anticipates will be the first of several HSO (Health Screening Option) units to be deployed at one of their client's manufacturing facilities.
• In 2020, Digital Surgery, a leader in surgical artificial intelligence, data, and analytics, was acquired by Medtronic (U.S.). As a result, Medtronic's portfolio and robot-assisted surgical platform have grown.

Global Medical Robotic System Market Scope

The medical robotic system market is segmented on the basis of type, product type, deployment type, service, application and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Traditional Robots
• Collaborative robots

Product Type

• Surgical Robotic Systems
• Telepresence Robots
• Rehabilitative Robotic Systems
• Exoskeleton Robots
• Prosthetic Robots
• Assistive Robots
• Non-Invasive Radiosurgery Robots
• Hospital and Pharmacy Robotic Systems
• Medical Service Robot
• Clean Room Robots
• Robotic Prosthetics
• Marginal Propensity to Consume Prosthetics
• Myoelectrical Prosthetics

Deployment Type

• On-Premises
• Cloud Based

Services

• Instrument and Accessories
• Medical Service

Application

• Neurology
• Cardiology
• Orthopedics
• Urology
• Pharmacy
• Physical Rehabilitation
• Gynecology
• Laparoscopy
• Radiation Therapy
• Special Education

End Users

• Hospitals
• Ambulatory Surgical Centers
• Rehabilitation Centers
• Pharmacy
• Others

Medical Robotic System Market Regional Analysis/Insights

The medical robotic system market is analysed and market size insights and trends are provided by country, type, product type, deployment type, service, application and end users as referenced above.

The countries covered in the medical robotic system market report are  U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the market and will continue to flourish its trend of dominance during the forecast period. The major factors attributable to the region’s dominance are strong base of healthcare facilities, growing investment from major players in the development of advanced devices, a higher adoption rate of minimally invasive surgery among patients, and growing research activity.  

Asia-Pacific will undergo the highest growth rate during the forecast period owing to the expansion of government initiatives to raise public awareness, an increase in medical tourism, expanding research activities in the region, an increase in the incidence of acute and chronic diseases, and the region's growing demand for high-quality healthcare.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Medical Robotic System Market Share Analysis

The medical robotic system market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to medical robotic system market.

Some of the major players operating in the medical robotic system market are:

• iRobot Corporation (U.S.)
• Titan Medical Inc. (Canada)
• Hansen Technologies (Australia)
• Renishaw plc (U.K.)
• Intuitive Surgical (U.S.)
• Medtronic (Ireland)
• DENSO Robotics Incorporated (U.S.)
• Accuray Incorporated (U.S.)
• Stryker (U.S.)
• Varian Medical Systems, Inc. (U.S.)
• Stereotaxis, Inc. (U.S.)
• Ekso Bionics (U.S.)
• CYBERDYNE INC. (Japón)
• BIONIK (Estados Unidos)
• Smith & Nephew plc (Reino Unido)
• Zimmer Biomet (Estados Unidos)
• Omnicell Inc. (Estados Unidos)
• ARxIUM (Canadá)

SKU-1316